Clinical trial
A Multicenter Open Label Phase 2 Study of Carfilzomib Weekly Plus Melphalan and Prednisone in Untreated Symptomatic Elderly Multiple Myeloma
NCT02302495 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Open Label Phase 2 Study of Carfilzomib Weekly Plus Melphalan and Prednisone in Untreated Symptomatic Elderly Multiple Myeloma
- Lead sponsor
- University Hospital, Lille
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 8, 2014
- Completion date
- July 31, 2021
- Enrollment
- 32 (actual)
- Sites
- 33
Conditions
As the registry lists them; a condition with its own page is linked.